HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pia Bernasconi Selected Research

Muscular Atrophy (Muscle Atrophy)

5/2021Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pia Bernasconi Research Topics

Disease

15Myasthenia Gravis
06/2022 - 08/2003
9Inflammation (Inflammations)
12/2020 - 01/2011
7Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
12/2018 - 11/2002
6Fibrosis (Cirrhosis)
12/2018 - 11/2002
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2020 - 01/2015
5Muscular Dystrophies (Muscular Dystrophy)
01/2018 - 11/2002
4Myotonia
01/2021 - 09/2013
3Disease Progression
01/2022 - 01/2020
3Channelopathies
01/2021 - 10/2016
3Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2018 - 11/2005
3Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
01/2018 - 06/2012
3Thymoma (Thymic Carcinoma)
11/2017 - 07/2005
2Muscular Diseases (Myopathy)
01/2022 - 01/2018
2Myotonic Disorders (Paramyotonia Congenita)
01/2021 - 01/2019
2Neuromuscular Diseases (Neuromuscular Disease)
01/2020 - 11/2005
2Laminopathies
01/2020 - 01/2018
2Encephalitis (Encephalitis, Rasmussen)
10/2019 - 10/2002
2Infections
06/2019 - 01/2018
2Seizures (Absence Seizure)
06/2019 - 10/2002
2Inborn Genetic Diseases (Disease, Hereditary)
03/2019 - 09/2013
2Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
03/2019 - 07/2010
2Necrosis
12/2018 - 12/2011
2Multiple Sclerosis
12/2016 - 04/2004
2Myotonia Congenita (Thomsen Disease)
10/2016 - 09/2013
2Epstein-Barr Virus Infections
04/2016 - 01/2011
2Thymus Hyperplasia
09/2003 - 08/2003
1Central Core Myopathy (Central Core Disease)
01/2022
1Minicore Myopathy with External Ophthalmoplegia
01/2022
1Muscular Atrophy (Muscle Atrophy)
05/2021
1Paralysis (Palsy)
01/2021
1Pain (Aches)
01/2021
1Cardiac Arrhythmias (Arrythmia)
01/2021
1Neuroinflammatory Diseases
12/2020
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2020
1Partial Epilepsies (Epilepsy, Partial)
10/2019
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2019
1Aphasia (Dysphasia)
10/2019
1Autoimmune Diseases of the Nervous System
10/2019
1Relapsing-Remitting Multiple Sclerosis
10/2019
1Epileptic Syndromes
06/2019
1Potassium aggravated myotonia
01/2019
1Oculopharyngeal Muscular Dystrophy
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Inclusion Body Myositis
01/2018
1type 1B Limb-girdle muscular dystrophy
01/2018
1Lmna-Related Congenital Muscular Dystrophy
01/2018

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2002
8MicroRNAs (MicroRNA)IBA
05/2021 - 01/2015
7Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 07/2005
5Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2018
5AntibodiesIBA
01/2020 - 10/2002
5AutoantibodiesIBA
01/2020 - 04/2004
5Messenger RNA (mRNA)IBA
01/2019 - 11/2002
5CollagenIBA
12/2018 - 11/2002
4Cholinergic ReceptorsIBA
04/2016 - 07/2005
4Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2006 - 11/2002
3CytokinesIBA
01/2020 - 11/2002
2Sodium Channels (Sodium Channel)IBA
01/2021 - 10/2015
2ChemokinesIBA
12/2020 - 01/2020
2Interleukin-4 (Interleukin 4)IBA
01/2020 - 11/2016
2Therapeutic UsesIBA
01/2020 - 06/2019
2Phosphatidylinositols (Phosphatidylinositol)IBA
06/2019 - 01/2019
2Epstein-Barr virus encoded RNA 1IBA
11/2017 - 01/2011
2Azathioprine (Imuran)FDA LinkGeneric
01/2017 - 01/2013
2DystrophinIBA
05/2014 - 06/2006
2Sarcoglycans (beta Sarcoglycan)IBA
05/2014 - 11/2005
2DecorinIBA
05/2014 - 11/2005
2Phosphotransferases (Kinase)IBA
01/2013 - 10/2011
2Cholinesterase Inhibitors (Anticholinesterases)IBA
07/2010 - 08/2003
1Complement System Proteins (Complement)IBA
06/2022
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2022
1Buprenorphine (Subutex)FDA LinkGeneric
01/2021
1SodiumIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1SteroidsIBA
10/2019
1Inosine Triphosphate (ITP)IBA
10/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2019
1Alemtuzumab (Campath)FDA Link
10/2019
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2019
1InterleukinsIBA
06/2019
1Sodium Channel BlockersIBA
01/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1FM19G11IBA
01/2019
1Mexiletine (Mexitil)FDA LinkGeneric
01/2019
1Voltage-Gated Sodium ChannelsIBA
01/2019
1Caveolin 1IBA
12/2018
1CardiotoxinsIBA
12/2018
1Lamin Type A (Lamin A)IBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
11/2017
1Small Nuclear RNA (snRNA)IBA
11/2017

Therapy/Procedure

7Therapeutics
06/2022 - 01/2008
2Precision Medicine
10/2019 - 10/2018
2Thymectomy
09/2003 - 08/2003
1Denervation
12/2020